Manning & Napier Advisors LLC Astrazeneca PLC Transaction History
Manning & Napier Advisors LLC
- $8.76 Trillion
- Q4 2024
A detailed history of Manning & Napier Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 3,745,531 shares of AZN stock, worth $276 Million. This represents 2.8% of its overall portfolio holdings.
Number of Shares
3,745,531
Previous 3,181,234
17.74%
Holding current value
$276 Million
Previous $248 Billion
0.99%
% of portfolio
2.8%
Previous 2.73%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
475MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.45 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.03 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.77 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.44 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...